Pablo González Montaner

Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.

D. van Soolingen, V. Ritacco, M. Vescovo, 2012, The Journal of antimicrobial chemotherapy.

Patients with Multidrug-Resistant Tuberculosis Display Impaired Th1 Responses and Enhanced Regulatory T-Cell Levels in Response to an Outbreak of Multidrug-Resistant Mycobacterium tuberculosis M and Ra Strains

L. Balboa, P. Schierloh, M. Sasiain, 2009, Infection and Immunity.

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Alimuddin Zumla, K. Dheda, A. Spanevello, 2017, European Respiratory Journal.

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.

K. Dheda, A. Spanevello, R. Duarte, 2019, The Journal of infection.

Transforming growth factor-β, Interleukin-23 and interleukin-1β modulate TH22 response during active multidrug-resistant tuberculosis.

S. de la Barrera, N. Yokobori, B. Bartoletti, 2023, Immunology.

Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi‐drug‐resistant tuberculosis

M. Sasiain, D. Palmero, S. de la Barrera, 2020, Clinical and experimental immunology.